Tag Archives: Intrexon
The CEO of Intrexon (NASDAQ: XON) is Buying Shares
Today, the CEO of Intrexon (XON – Research Report), Randal Kirk, bought shares of XON for $3.69M. Following this transaction Randal Kirk’s holding in the company was increased by 1.78% to a total of $217 million. See today’s analyst top
Northland Securities Sticks to Their Hold Rating for Intrexon (XON)
Northland Securities analyst Robert Breza maintained a Hold rating on Intrexon (XON – Research Report) today and set a price target of $7. The company’s shares closed yesterday at $4.34, close to its 52-week low of $3.95. Breza observed: “We
JMP Securities Thinks Intrexon’s Stock is Going to Recover
JMP Securities analyst Jason Butler reiterated a Buy rating on Intrexon (XON – Research Report) on March 1 and set a price target of $43. The company’s shares closed yesterday at $5.02, close to its 52-week low of $4.05. According
Analysts Offer Insights on Healthcare Companies: Intrexon (NYSE: XON) and Puma Biotechnology (NYSEArca: PBYI)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Intrexon (NYSE: XON) and Puma Biotechnology (NYSEArca: PBYI). Intrexon (NYSE: XON) In a report released today, Robert Breza from Northland Securities reiterated a
A Director at Intrexon is Exercising Options
Yesterday, a Director at Intrexon, Steven Frank, exercised options of Intrexon for $23.51K. The options were close to expired and Steven Frank retained stocks. Following this transaction Steven Frank’s holding in the company was increased by 4.94% to a total
Northland Securities Thinks Intrexon’s Stock is Going to Recover
Northland Securities analyst Robert Breza reiterated a Buy rating on Intrexon (NYSE: XON) yesterday and set a price target of $21. The company’s shares closed yesterday at $11.81, close to its 52-week low of $11.80. According to TipRanks.com, Breza is
